DeepDyve
Login
Login failed. Please try again.
Forgot your password?
Login with Facebook
Close
Please enable Javascript on your browser for a better experience on DeepDyve.
Enter a sentence, or cut and paste a paragraph
Refine
Advanced Filters »
All Edit
Select All | Select None
Reset filters Search
Journals The FASEB Journal December 2009
To view this document, you will need to have Adobe Flash Player 10 or above installed.Please click here to install.
Several types of terminally differentiated somatic cells can be reprogrammed into a pluripotent state by ectopic expression of Klf4, Oct3/4, Sox2, and c-Myc. Such induced pluripotent stem (iPS) cells have great potential to serve as an autologous source of cells for tissue repair. In the process of developing iPS-cell-based therapies, the major goal is to determine whether differentiated cells derived from iPS cells, such as cardiomyocytes (CMs), have the same functional properties as their physiological in vivo counterparts. Therefore, we differentiated murine iPS cells to CMs in vitro and characterized them by RT-PCR, immunocytochemistry, and electrophysiology. As key markers of cardiac lineages, transcripts for Nkx2.5, MHC, Mlc2v, and cTnT could be identified. Immunocytochemical stainings revealed the presence of organized sarcomeric actinin but the absence of mature atrial natriuretic factor. We examined characteristics and developmental changes of action potentials, as well as functional hormonal regulation and sensitivity to channel blockers. In addition, we determined expression patterns and functionality of cardiac-specific voltage-gated Na + , Ca 2+ , and K + channels at early and late differentiation stages and compared them with CMs derived from murine embryonic stem cells (ESCs) as well as with fetal CMs. We conclude that iPS cells give rise to functional CMs in vitro , with established hormonal regulation pathways and functionally expressed cardiac ion channels; CMs generated from iPS cells have a ventricular phenotype; and cardiac development of iPS cells is delayed compared with maturation of native fetal CMs and of ESC-derived CMs. This difference may reflect the incomplete reprogramming of iPS cells and should be critically considered in further studies to clarify the suitability of the iPS model for regenerative medicine of heart disorders.—Kuzmenkin, A., Liang, H., Xu, G., Pfannkuche, K., Eichhorn, H., Fatima, A., Luo, H., ari , T., Wernig, M., Jaenisch, R., Hescheler, J. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro .
To view this document, you will need to have Adobe Flash Player 10 or above installed. Please click here to install.
This is a preview. The total pages displayed will be limited.
Rent for $0.99 FREE
It seems like you have an account, please login to rent this article
Don't have an account yet? Sign up now!
To view the full-text of this article, sign up for a free DeepDyve account below.
A free Basic account also comes with 3 free rentals to help get you started.
Just 30 seconds to go! Please check your inbox for a confirmation email to activate your account, then start using your 3 FREE rentals.
Sign up with your Facebook account
Learn more Existing user? Login here
Share this article: facebook twitter
Browse: Subject Areas | Journals | Publishers
© 2010 DeepDyve, Inc. All rights reserved. Terms of Service | Privacy Policy
To bookmark an article, please log in first, or sign up for a DeepDyve account if you don't already have one.
OK
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don't already have one.